TipRanks on MSN

MapLight’s phase 2 Alzheimer’s psychosis trial marks a key milestone for MPLT investors

MapLight Therapeutics, Inc. ($MPLT) announced an update on their ongoing clinical study. MapLight Therapeutics Advances Mid-Stage Trial for ...
TipRanks on MSN

Altimmune’s IMPACT NASH trial completion puts pemvidutide back in the spotlight

Altimmune ($ALT) announced an update on their ongoing clinical study. Altimmune’s IMPACT trial, officially titled “A Phase 2, Multicenter, ...
Applied Clinical Trials Online

Gilead’s ARTISTRY-2 Trial Shows Bictegravir Lenacapavir Combo Matches Biktarvy in Virologically Suppressed Adults With HIV

Gilead's ARTISTRY-2 trial shows BIC/LEN is non-inferior to Biktarvy in virologically suppressed adults with HIV, with no new safety signals. ARTISTRY-2's design involved a randomized, double-blind ...
European Medical Journal

Trial Examines Azathioprine in Early Parkinson’s Disease

UK trial has found that azathioprine does not slow progression in early Parkinson’s disease, despite good tolerability. The ...
BMJ Open

High-dose intermittent theta burst stimulation targeting the individualised frontoparietal cognitive network for post-stroke cognitive impairment: protocol for a randomised ...

Introduction Cognitive impairment is a common consequence after stroke. Intermittent theta burst stimulation (iTBS) has emerged as a promising cognitive therapy. However, traditional iTBS typically ...